EMA press briefing to inform on CHMP discussion on booster doses

Date: 05/10/2021
Location: Online
Twitter: #EMAPresser

Video recording


To view the broadcast please ensure you meet the YouTube requirements.

To view the video in the highest quality, click on the 'Settings' symbol in the right-hand corner of the video player and select '720p' or a higher resolution.

Event summary

The European Medicines Agency (EMA) is holding a press briefing on Tuesday, 5 October 2021. As the Committee for Medicinal Products for Human Use (CHMP) will discuss third doses and booster doses for some COVID-19 vaccines at a meeting on Monday, 4 October, attendees have the opportunity to ask questions on the CHMP’s considerations as well as on EMA’s other COVID-19 activities.


  • Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
  • Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
  • Georgy Genov (Head of Pharmacovigilance)

The press briefing will be moderated by Marie-Agnes Heine (Head of Communications).

The press briefing will be held in English. No translations will be provided.

How useful was this page?

Add your rating
6 ratings
10 ratings
8 ratings
3 ratings